Abortion Pill’s Safety Called into Question in Congressional Actions Based on Misleading Data Joel Luther , Hagere Yilma , and Irving Washington

https://www.kff.org/health-information-trust/abortion-pills-safety-called-into-question-in-congressional-actions-based-on-misleading-data/?utm_campaign=22234741-KFF-Information-Trust&utm_medium=email&_hsenc=p2ANqtz--IuCgEDPU5PrYylo9La5cVCrCzA9yxkN0V2DqExX-zNgAwvw9CGTazyaV_7T64rsGXUIpthw5hlw448sjFoYHtx_GRqA&_hsmi=412873377&utm_content=412873377&utm_source=hs_email False claims about the safety of mifepristone, the abortion pill used in roughly two-thirds of U.S. abortions, are driving legislative and investigative action in Congress, even as major medical organizations and decades of clinical evidence support the drug’s safety. The Monitor also examines how competing interpretations of what censorship and free speech mean for policy and law are contributing to recent developments, including a Supreme Court ruling, a federal lawsuit settlement, and new legal challenges with implications for how health misinformation is managed, moderated, and allowed to spread.